Follicle-stimulating hormone treatment of male infertility

Current Opinion in Urology

Volumn 18, Issue 6, 2008, Pages 602-607

  Foresta, Carlo ^a   Selice, Riccardo ^a   Garolla, Andrea ^a   Ferlin, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Follicle stimulating hormone; Hormonal treatment; Male infertility; Oligozoospermia; Semen parameters

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; INHIBIN B; RECOMBINANT FOLLITROPIN;

DRUG BINDING; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GENETIC POLYMORPHISM; GONADOTROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE INFERTILITY; OLIGOSPERMIA; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SERTOLI CELL; SPERMATID; SPERMATOCYTE; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON; SPERMATOZOON COUNT; SPERMATOZOON DENSITY;

BIOLOGICAL MARKERS; FEMALE; FERTILITY AGENTS, MALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, MALE; INHIBINS; MALE; PATIENT SELECTION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY RATE; RECEPTORS, FSH; SPERMATOGENESIS; TESTIS; TREATMENT OUTCOME;

EID: 55149121767     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328313647d     Document Type: Review

References (42)

1. Matsumoto AM, Karpas AE, Paulsen CA, Bremner WJ. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle stimulating hormone. J Clin Invest 1983; 72:1005-1015.
2. Matsumoto AM, Paulsen CA, Bremmer WJ. Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men. J Clin Endocrinol Metabol 1984; 59:882-887.
3. Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle stimulating hormone is necessary for the maintenance of quantitative normal spermatogenesis in men. J Clin Endocrinol Metabol 1986; 62:1184-1190.
4. Acosta AA, Oehninger S, Ertunc H, Philput C. Possible role of pure human follicle-stimulating hormone in the treatment of severe male infertility by assisted reproduction: preliminary report. Fertil Steril 1991; 55:1150-1156.
5. Acosta AA, Khalifa E, Oehninger S. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 1992; 7:1067-1072.
6. Matorras R, Perez C, Corcostegui B, et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod 1997; 12:24-28.
7. Kamischke A, Behre HM, Bergmann M, et al. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998; 13:596-603.
8. Ben-Rafael Z, Farhi J, Feldberg D, et al. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 2000; 73:24-30.
9. Bartoov B, Elles F, Lunenfeld E, et al. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 1994; 61:727-734.
10. Sigg C, Baclu M. Improvement of sperm concentration and bovine mucus penetration in idiopathic oligozoospermia by administration of pure FSH. Hum Reprod 1994; 9:47.
11. Merino G, Carranza-Lira S, Martinez-Chequer JC. Sperm characteristics and hormonal profile before and after treatment with follicle-stimulating hormone in infertile patients. Arch Androl 1996; 37:197-200.
12. Glander HJ, Kratzsch J. Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotropin-releasing hormone (GnRH). Andrologia 1997; 29:23-28.
13. Strehler E, Sterzik K, De Santo M, et al. The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. J Androl 1997; 18:439-447.
14. Van Alphen MMA, Van de Kant HJG, De Roojj DG. Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey. Endocrinology 1988; 123:1449-1455.
15. Dias JA, Lindau-Shepard B, Hauer C, Auger I. Human follicle-stimulating hormone structure-activity relationships. Biol Reprod 1998; 58:1331-1336.
16. Nieschlag E, Simoni M, Gromoll J. Role of FSH in the regulation of spermatogenesis. Clin Endocrinol 1999; 51:139-146.
17. Martin-Johnston M, Beltsos AN, Grotjan HE, Uhler ML Adding human menopausal gonadotrophin to antagonist protocols - is there a benefit? Reprod Biomed Online 2007; 15:161-168. The above study provides elucidation about the action of FSH on ovarian tissue.
18. Moudgal NR, Sairam MR. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Hum Reprod 1998; 13:916-991.
19. Mastrogiacomo I, Motta RG, Botteon S, et al. Achievement of spermatogenesis and genital tract maturation in hypogonadotropic hypogonadic subjects during long term treatment with gonadotropins or LHRH. Andrologia 1991; 23:285-289.
20. Burgues S, Calderon MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish collaborative group on male hypogonadotrophic hypogonadism. Hum Reprod 1997; 12:980-986.
21. Ashkenazi J, Bar-Hava I, Farhi J, et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 1999; 72:670-673.
22. Baccetti B, Strehler E, Capitani G, et al. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae). Hum Reprod 1997; 12:1955-1968.
23. Foresta C, Varotto A. Assessment of testicglar cytology by fine needle aspiration as a diagnostic parameter in evaluation of the oligozoospermic subject. Fertil Steril 1992; 58:1028-1033.
24. Foresta C, Varotto A, Scandellari C. Assessment of testicular cytology by fine needle aspiration as a diagnostic parameter in evaluation of the azoospermic subject. Fertil Steril 1992; 57:858-865.
25. Foresta C, Ferlin A, Bettella A, et al. Diagnostic and clinical features in azoospermia. Clin Endocrinol 1995; 43:537-543.
26. Foresta C, Bettella A, Ferlin A, et al. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 1998; 69:636-642.
27. Foresta C, Bettella A, Merico M, et al. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 2000; 161:89-97.
28. Jensen TK, Andersson AM, Hjollund NH, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metabol 1997; 82:4059-4063.
29. Mahmoud AM, Comhaire FH, Depuydt CE. The clinical and biologic significance of serum inhibins in subfertile men. Reprod Toxicol 1998; 12:591-599.
30. Uhler ML, Zinaman MJ, Brown CC, Clegg ED. Relationship between sperm characteristics and hormonal parameters in normal couples. Fertil Steril 2003; 79 (Suppl 3):1535-1542.
31. Meeker JD, Godfrey-Bailey L, Hauser R. Relationships between serum hormone levels and semen quality among men from an infertility clinic. J Androl 2007; 28:397-406. The above study provides relationships between FSH and semen quality.
32. Andersson AM, Petersen JH, Jargensen N, et al. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab 2004; 89:2873-2879.
33. Foresta C, Bettella A, Garolla A, et al. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005; 84:654-661.
34. lsidori AM, Pozza C, Gianfrilli D, Isidori A. Medical treatment to improve sperm quality. Reprod Biomed Online 2006; 12:704-714.
35. Airtomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82:959-968.
36. Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metabol 2005; 90:4866-4872.
37. Behre HM, Grab RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenetics Genomics 2005; 15:451-456.
38. Simoni M, Gromoll J, Höppner W, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metabol 1999; 84:751-755.
39. Asatiani K, Gromoll J, Eckardstein SV, et al. Distribution and function of FSH receptor genetic variants in normal men. Andrologia 2002; 34:172-176.
40. Ahda Y, Gromoll J, Wunsch A, et al. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 2005; 26:494-499.
41. Pengo M, Ferlin A, Arredi B, et al. FSH receptor gene polymorphisms in fertile and infertile Italian men. Reprod Biomed Online 2006; 13:795-800.
42. Perez Mayorga M, Gromoll J, Behre HM, et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metabol 2000; 85:3365-3369.